Statistics
Publications
1
Citations
16
H-Index
1
Active since
2020
Affiliations
Stanford University(Current)
Shreyana Bolleddu is an author at Stanford University specializing in immune checkpoint inhibitor therapy, oncology, and complete response assessment.
Publications per year
2020–2020
1
1
Nivolumab Plus Ipilimumab for Soft Tissue Sarcoma: A Single Institution Retrospective Review
Maggie Zhou, Nam Q. Bui, Shreyana Bolleddu et al. · Immunotherapy · 2020 · 16 citations
Medicine, Oncology, Pharmacotherapy +17
1–1 of 1